# Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin)

> **NCT00933738** · — · COMPLETED · sponsor: **Abbott RDx Cardiometabolic** · enrollment: 150 (estimated)

## Conditions studied

- Coagulation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00933738
- **Lead sponsor:** Abbott RDx Cardiometabolic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-12
- **Final completion:** 2011-03
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2011-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00933738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00933738, "Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00933738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*